Nurix CEO and key executive team

• Arthur T. Sands

  President, Chief Executive Officer and Director
• Hans van Houte

  Chief Financial Officer
• Gwenn M. Hansen

  Chief Scientific Officer
• Stefani A. Wolff

  Chief Operating Officer and Executive Vice President, Product Development
• Lori A. Kunkel

  Director
• Michael T. Lotze

  Chief Cellular Therapy Officer
• Michael Blackton

  Senior Vice President of Cell Therapy Manufacturing
• Jason Kantor

  Executive Vice President, Finance and Business Strategy
• Christine Ring

  General Counsel and Secretary
• Frederick Cohen

  Vice President of Medicinal Chemistry
• Su Young Kim

  Vice President of Clinical Development
• Raf Lambrecht

  Vice President and Head of Regulatory
• James Nelson

  Vice President of Quality Assurance
• Christopher B. Phelps

  Vice President and Head of Early Discovery
• Janine Powers

  Vice President and Head of Translational Medicine
• Seema P. Rogers

  Vice President, Head of Clinical Operations
• Kim Trahan

  Vice President and Head of Program and Portfolio Management
• Ena Wang

  Vice President of Cell Therapy and Product Development
• Cristiana Guiducci

  Senior Vice President, Immunology, and Oncology Research
• Robert J. Brown

  Executive Vice President, Head of Clinical Development

Source: nurix-inc.com, nurixtx.com, nurixtx.com, nurixtx.com, nurixtx.com, nurixtx.com